Zileuton D4
| Product Name | Zileuton D4 |
|---|---|
| Alternate Names | Zileuton Stable Isotopes, Stable Isotopes of Zileuton |
| CAT No. | CS-O-02865 |
| CAS No. | 1189878-76-9 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 240.31 g/mol |
| Mol. For. | C₁₁H₈D₄N₂O₂S |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Zileuton |
| Purity | Not less than 90 % |
| Therapeutic | Anti-Asthma / COPD |
| Smileys | ON(C(N)=O)C(C1=CC2=CC=CC=C2S1)([2H])C([2H])([2H])[2H] |
| Canonical Smiles | CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O |
| InchIKey | MWLSOWXNZPKENC-CWIRFKENSA-N |
| Inchl | InChI=1S/C11H12N2O2S/c1-7(13(15)11(12)14)10-6-8-4-2-3-5-9(8)16-10/h2-7,15H,1H3,(H2,12,14)/i1D3,7D |
| IUPAC | 1-[1-(1-benzothiophen-2-yl)-1,2,2,2-tetradeuterioethyl]-1-hydroxyurea |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Zileuton D4 is a deuterated form of Zileuton, which is a selective inhibitor of 5-lipoxygenase (5-LO), an enzyme that is responsible for the production of leukotrienes (LTs). LTs are potent inflammatory mediators that play a critical role in the pathogenesis of various inflammatory diseases, such as asthma and chronic obstructive pulmonary disease (COPD).
Zileuton D4 is primarily used in the research and development of novel therapeutic agents for the treatment of these inflammatory diseases. It is also used as a reference standard in pharmacokinetic and pharmacodynamic studies to determine the efficacy, safety, and mechanism of action of new drugs.
Chemically, Zileuton D4 is a deuterated derivative of Zileuton, which means that it contains four deuterium atoms in place of four hydrogen atoms. This modification improves the pharmacokinetic properties of the drug, such as its bioavailability, half-life, and metabolic stability, which enhances its therapeutic potential.
In summary, Zileuton D4 is a valuable tool for researchers and pharmaceutical companies to develop new and effective drugs for the treatment of inflammatory diseases. Its chemical modification provides improved properties that make it a useful reference standard in pharmacological studies.
Get an Instant Quote
Related Compounds
Zileuton-13C2,15N |